✦ LIBER ✦

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia

✍ Scribed by Jazbec, J; Aplenc, R; Dolzan, V; Debeljak, M; Jereb, B

Book ID: 110055692
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 79 KB
Volume: 17
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2403164

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second Malignant Neoplasms After Treatme

Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

✍ Schmiegelow, K.; Levinsen, M. F.; Attarbaschi, A.; Baruchel, A.; Devidas, M.; Es 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 318 KB

DNA repair polymorphisms influence the r

DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia

✍ Nina Erčulj, Barbara Faganel Kotnik, Maruša Debeljak, Janez Jazbec, Vita Dolžan 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Second malignant neoplasms after treatme

Second malignant neoplasms after treatment of childhood cancer

✍ G Klein; J Michaelis; C Spix; R Wibbing; G Eggers; J Ritter; P Kaatsch 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Second Malignant Neoplasms after Success

Second Malignant Neoplasms after Successful Treatment of Childhood Cancers

✍ Stephen A. Feig 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Second malignancy after treatment of chi

Second malignancy after treatment of childhood acute myeloid leukemia

✍ Leung, W; Ribeiro, R C; Hudson, M; Tong, X; Srivastava, D K; Rubnitz, J E; Sandl 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

Long-term risk of second malignant neopl

Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment

✍ Carole Rubino; Elisabeth Adjadj; Sylvie Guérin; Catherine Guibout; Akhtar Shamsa 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 90 KB

## Abstract The aim of our study was to quantify the risk of second malignant neoplasms (SMNs) among long‐term survivors of neuroblastoma and to study the influence of treatment on this risk. We studied data from 544 5‐year survival patients diagnosed with neuroblastoma before age 16 years at 8 Fre